Marathon Pharma

How Big Pharma Might Be Cut Down To Size
Forbes
Thu, 05/11/17 - 06:34 pm
Big Pharma
drug pricing
Emflaza
Marathon Pharma
After being spurned at the FDA, PTC buys a controversial Duchenne MD therapy from Marathon
Endpoints
Thu, 03/16/17 - 09:48 am
FDA
PTC Therapeutics
Duchenne Muscular Dystrophy
Emflaza
Marathon Pharma
Eight senators pile on to Marathon's Emflaza—and its $89,000 pricing blunder
Fierce Pharma
Mon, 03/6/17 - 11:55 am
Senate
Marathon Pharma
Emflaza
drug pricing
PhRMA disses Marathon CEO—and PhRMA board member—Jeff Aronin after latest price gouging controversy
Endpoints
Thu, 02/16/17 - 03:12 pm
PhRMA
Marathon Pharma
drug pricing
Marathon halts launch of DMD drug as $89K price attracts congressional heat
Fierce Pharma
Tue, 02/14/17 - 12:12 pm
Marathon Pharma
Duchenne Muscular Dystrophy
drug pricing
Bernie Sanders
Emflaza
The scoop: Marathon’s R&D program for Duchenne MD drug likely came in at a bargain basement price
Endpoints
Mon, 02/13/17 - 10:00 am
Marathon Pharma
R&D
Duchenne Muscular Dystrophy
Emflaza
Why Did That Drug Price Increase 6,000%? It's The Law
Forbes
Sat, 02/11/17 - 12:40 pm
drug pricing
deflazacort
generics
Duchenne Muscular Dystrophy
Emflaza
Marathon Pharma
FDA approves Marathon Pharma's Duchenne muscular dystrophy drug
Marketwatch
Thu, 02/9/17 - 09:29 pm
FDA
Marathon Pharma
Duchenne Muscular Dystrophy
Emflaza
Thumbs Up/Thumbs Down: The FDA backs another R&D scheme, Kite shows its speed while Eli Lilly and Astra stumble again
Endpoints
Fri, 08/12/16 - 11:05 am
FDA
R&D
Kite Pharma
AstraZeneca
Marathon Pharma
Eli Lilly
Marathon Pharma latest company to try for approval of Duchenne drug
BioPharma Dive
Wed, 06/15/16 - 05:43 pm
Marathon Pharma
Duchenne Muscular Dystrophy